[go: up one dir, main page]

MX2009004557A - Composicion farmaceutica granulada seca y metodos para producirla. - Google Patents

Composicion farmaceutica granulada seca y metodos para producirla.

Info

Publication number
MX2009004557A
MX2009004557A MX2009004557A MX2009004557A MX2009004557A MX 2009004557 A MX2009004557 A MX 2009004557A MX 2009004557 A MX2009004557 A MX 2009004557A MX 2009004557 A MX2009004557 A MX 2009004557A MX 2009004557 A MX2009004557 A MX 2009004557A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
methods
producing same
dry granulated
granulated pharmaceutical
Prior art date
Application number
MX2009004557A
Other languages
English (en)
Inventor
John Cunningham
Abraham B Bashai-Woldu
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2009004557A publication Critical patent/MX2009004557A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporciona un método para el procesamiento de granulación en seco de una composición farmacéutica, para proporcionar composiciones farmacéuticas granuladas con características mejoradas de flujo y cantidades reducidas de partículas finas.
MX2009004557A 2006-10-27 2007-10-26 Composicion farmaceutica granulada seca y metodos para producirla. MX2009004557A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86331706P 2006-10-27 2006-10-27
PCT/US2007/022762 WO2008051617A2 (en) 2006-10-27 2007-10-26 Dry granulated pharmaceutical compositions and methods for producing same

Publications (1)

Publication Number Publication Date
MX2009004557A true MX2009004557A (es) 2009-05-11

Family

ID=39272398

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004557A MX2009004557A (es) 2006-10-27 2007-10-26 Composicion farmaceutica granulada seca y metodos para producirla.

Country Status (10)

Country Link
US (1) US20080102130A1 (es)
EP (1) EP2086512A2 (es)
JP (1) JP2010508270A (es)
KR (1) KR20090074263A (es)
CN (1) CN101568329A (es)
AU (1) AU2007309408A1 (es)
BR (1) BRPI0718320A2 (es)
CA (1) CA2667925A1 (es)
MX (1) MX2009004557A (es)
WO (1) WO2008051617A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015014980A1 (en) * 2013-08-02 2015-02-05 Ratiopharm Gmbh Composition comprising tapentadol in a dissolved form
EP3875077B1 (en) 2020-03-02 2023-12-13 Grünenthal GmbH Dosage form providing prolonged release of tapentadol phosphoric acid salt
BR112022017700A2 (pt) 2020-03-02 2023-01-17 Gruenenthal Gmbh Forma de dosagem fornecendo liberação prolongada de sal de ácido fosfórico de tapentadol
WO2022101247A1 (de) 2020-11-10 2022-05-19 Grünenthal GmbH Darreichungsformen mit verlängerter freisetzung eines salzes von tapentadol mit l-(+)-weinsäure
DE202020005470U1 (de) 2020-11-10 2022-01-25 Grünenthal GmbH Darreichungsformen mit verlängerter Freisetzung eines Salzes von Tapentadol mit L-(+)-Weinsäure
HUE059465T2 (hu) 2020-11-10 2022-11-28 Gruenenthal Gmbh A tapentadol L-(+)- borkõsav-só késleltetett felszabadulású adagolási formája

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4670251A (en) * 1984-05-30 1987-06-02 Igene Biotechnology, Inc. Microcrystalline tableting excipient derived from whey
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US5403593A (en) * 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms
PL372394A1 (en) * 2002-02-01 2005-07-25 Pfizer Products Inc. Dry granulated formulations of azithromycin

Also Published As

Publication number Publication date
US20080102130A1 (en) 2008-05-01
EP2086512A2 (en) 2009-08-12
JP2010508270A (ja) 2010-03-18
AU2007309408A1 (en) 2008-05-02
WO2008051617A2 (en) 2008-05-02
WO2008051617A9 (en) 2008-06-26
WO2008051617A3 (en) 2009-03-05
CN101568329A (zh) 2009-10-28
KR20090074263A (ko) 2009-07-06
BRPI0718320A2 (pt) 2013-11-26
CA2667925A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
SG150075A1 (en) Particles for delivery of active ingredients, process of making and compositions thereof
PH12015500301A1 (en) A novel formulation of diclofenac
MY159098A (en) Production of encapsulated nanoparticles at high volume fractions
MX2009004557A (es) Composicion farmaceutica granulada seca y metodos para producirla.
NZ595985A (en) A novel formulation of naproxen
MY161430A (en) A method for producing a composition of meloxicam
MY159208A (en) A novel formulation of indomethacin
ZA200903305B (en) Concentrated Surfactant Compositions
MX2013007057A (es) Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos.
NZ591146A (en) Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills
MX2009000023A (es) Diferenciacion de celulas madre de matriz de cordon umbilical en celulas de linaje hepatocitico.
MX360019B (es) Una formulación novedosa de metaxalona.
IN2009DN08217A (es)
EP2104554A4 (en) particle compositions
TW200730510A (en) Chroman compounds
UA95088C2 (ru) Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения
WO2011087765A3 (en) Methods of producing stabilized solid pharmaceutical compositions containing morphinans
UA93540C2 (ru) Фармацевтическая композиция для аэрозольного распыления c двумя действующими веществами и, по меньшей mepe, одним поверхностно-активным веществом
WO2008103560A3 (en) Improved process for the manufacture of polymer additive granules containing silica antiblock agents
TN2010000243A1 (en) Pharmaceutical composition
WO2012023145A3 (en) Prasugrel hydrochloride crystalline particles
ZA200900506B (en) Particles for delivery of active ingredients, process of making and compositions thereof
AU2014208310B2 (en) A Novel Formulation of Diclofenac
NZ710321A (en) Production of encapsulated nanoparticles at high volume fractions
PL380096A1 (pl) Sposób wytwarzania pelet z mieszanki węgla z dowolnym rodzajem biomasy

Legal Events

Date Code Title Description
FA Abandonment or withdrawal